NCT02328287View on ClinicalTrials.gov

Study on Allogeneic Osteoblastic Cells Implantation in Rescue Interbody Fusion

PHASE2TerminatedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

April 30, 2018

Study Completion Date

April 30, 2020

Conditions
Failed Lumbar Fusion
Interventions
DRUG

ALLOB®

Each patient will undergo a single administration of ALLOB® into the failed fusion lumbar level under anesthesia.

Trial Locations (3)

Unknown

Investigating site BE01, Anderlecht

Investigating site BE02, Charleroi

Investigating site BE04, Genk

Sponsors
All Listed Sponsors
lead

Bone Therapeutics S.A

INDUSTRY